Sage Journals: Discover world-class research

Open access

Review article

First published 2009

First-line Treatment of Metastatic Breast Cancer: Focus on Bevacizumab

Teruhiko Fujii, Hiroki Takahashi, Roka Namoto Matsubayashi [...]

Clinical Medicine Insights: Therapeutics

Open access

Review article

First published 2016-9

Bevacizumab as First-Line Treatment in HER2-Negative Advanced Breast Cancer: Pros and Cons

Valentina Sini, Alessandra Cassano, Domenico Corsi [...]

Tumori Journal

Retricted access

Research article

First published 2014-10

Comparative cost-effectiveness of bevacizumab-irinotecan-fluorouracil versus irinotecan-fluorouracil in first-line metastatic colorectal cancer

Oreto Ruiz-Millo, Asuncion Albert-Mari, Ana Sendra-Garcia [...]

Journal of Oncology Pharmacy Practice

Retricted access

Research article

First published 2024-11

Bevacizumab First in DRCR Protocol AC vs Real-World Physician Treatment Choice for Diabetic Macular Edema: Two-Year Cost Analysis

Dilraj S. Grewal, Ella Leung, Miguel Busquets [...]

Journal of VitreoRetinal Diseases

Open access

Research article

First published 2023

Real-world outcomes among patients with metastatic colorectal cancer treated first line with a bevacizumab biosimilar (bevacizumab-awwb)

Ran Jin, Adesuwa S. Ogbomo, Neil A. Accortt [...]

Therapeutic Advances in Medical Oncology

Retricted access

Research article

First published 2019-6

Discontinuation of first-line bevacizumab in metastatic colorectal cancer: the BEAWARE Italian Observational Study

Sara Lonardi, Guglielmo Nasti, Daniele Fagnani [...]

Tumori Journal

Retricted access

Case report

First published 2012-10

Intravitreal Bevacizumab for a Subfoveal Myopic Choroidal Neovascularization in the First Trimester of Pregnancy

Ugo Introini, Giuseppe Casalino, Anna Cardani [...]

Journal of Ocular Pharmacology and Therapeutics

Open access

Research article

First published 2021

Clinical and treatment characteristics of patients treated with the first therapeutic oncology biosimilars bevacizumab-awwb and trastuzumab-anns in the US

Ran Jin, Reshma L. Mahtani, Neil Accortt [...]

Therapeutic Advances in Medical Oncology

Retricted access

Research article

First published 2022-9

Correlation of response to intravitreal bevacizumab treatment between the first and second treated eyes in diabetic macular edema

Nadav Levinger, Liran Tiosano, Elishai Assayag [...]

European Journal of Ophthalmology

Open access

Research article

First published 2021

Pembrolizumab or Bevacizumab Plus Chemotherapy as First-Line Treatment of Advanced Nonsquamous Nonsmall Cell Lung Cancer: A Retrospective Cohort Study

Jie Zhang, Di Wu, Ziran Zhang [...]

Technology in Cancer Research & Treatment

Search results